Clinical trials
Terminated Breast Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
773 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 7 |
| 2001 | 6 |
| 2002 | 11 |
| 2003 | 17 |
| 2004 | 26 |
| 2005 | 25 |
| 2006 | 26 |
| 2007 | 52 |
| 2008 | 42 |
| 2009 | 49 |
| 2010 | 48 |
| 2011 | 30 |
| 2012 | 29 |
| 2013 | 40 |
| 2014 | 35 |
| 2015 | 36 |
| 2016 | 35 |
| 2017 | 42 |
| 2018 | 37 |
| 2019 | 47 |
| 2020 | 30 |
| 2021 | 28 |
| 2022 | 27 |
| 2023 | 20 |
| 2024 | 7 |
| 2025 | 6 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 773 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 38 |
| M.D. Anderson Cancer Center | 32 |
| Pfizer | 19 |
| Vanderbilt-Ingram Cancer Center | 16 |
| Mayo Clinic | 15 |
| Dana-Farber Cancer Institute | 14 |
| University of Southern California | 14 |
| Washington University School of Medicine | 14 |
| Novartis Pharmaceuticals | 12 |
| Emory University | 11 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 773 |
| Neoplasm Metastasis | 58 |
| Ovarian Neoplasms | 58 |
| Lung Neoplasms | 51 |
| Neoplasms | 50 |
| Colorectal Neoplasms | 45 |
| Triple Negative Breast Neoplasms | 44 |
| Carcinoma, Non-Small-Cell Lung | 42 |
| Breast Neoplasms, Male | 38 |
| Melanoma | 36 |
Trials
Showing 1 to 25 of 773. Each trial links to its page on Pharma Observatory.
673 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.